A Randomised Crossover Pilot Study of the Effects of Tezacaftor/Ivacaftor and Ivacaftor on Gastrointestinal Function Using Magnetic Resonance Imaging Parameters in People With Cystic Fibrosis
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Ivacaftor (Primary) ; Ivacaftor/tezacaftor (Primary)
- Indications Cystic fibrosis
- Focus Therapeutic Use
- Acronyms GIFT-CF2
Most Recent Events
- 14 Jan 2021 Status changed from active, no longer recruiting to completed.
- 09 Sep 2020 Planned End Date changed from 1 Aug 2020 to 1 Nov 2020.
- 09 Sep 2020 Planned primary completion date changed from 1 Aug 2020 to 1 Nov 2020.